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Hepatitis B Surface Antigen (HBs Ag): tryptophan Content and
Biological Activity (Accepted 24 May 1974) 
SUMMARY
The tryptophan content of hepatitis B surface antigen (HBoAg) was studied by spectrophotometric titration with N-bromosuccinimide (NBS) at pH 4"0 in 8.0 M-urea. A tryptophan value of I3"9 ~ or 22. 4 residues/mol (mol. wt. = 3oo0o) was obtained by this method. This value coupled with 2-3 mol per cent tyrosine content obtained by amino acid composition studies accounts for the unusually high extinction coefficient of HB~Ag (at 280 nm E~0~ = 37"26). The modification of tryptophan residues with NBS did not cause cleavage of the protein or loss of biologic activity as determined by radioimmunoassay.
Hepatitis B surface antigen (HB~Ag) (HB~Ag; Nomenclature, 1974) occurs as 20 nm virus-like particles in human serum and is remarkably stable to a variety of physicochemical treatments (Blumberg, Alter & Visnich, I965; Shulman, 197o; Krugman & Giles, 1972; Zuckerman, I972 ) . It is particularly resistant to treatment with proteolytic enzymes such as pepsin, trypsin, chymotrypsin and pronase (Kim & Bissel, 197I; Millman, Loeb & Bayer, i97o ) . Purified antigen has the unusually high extinction coefficient at 28o nm of EIo~ = 37"26 Gerin & Vyas, 1972 ) indicating a high molar concentration of tyrosine and tryptophan. Continuous scanning of the purified HB,Ag revealed a shoulder at 290 nm (Gerin & Vyas, I972) . Amino acid analysis has revealed only 2. 3 mol percent tyrosine (Vyas et al. I972) . Tyrosine and tryptophan ratio estimated by the method of Gaitonde & Dorey (197o) did not yield values to account for the high extinction coefficient (Vyas, Rao & Ibrahim, I972) . Therefore, we have estimated the tryptophan content by spectrophotometric titration with N-bromosuccinimide (NBS) according to the method of Patchornik, Lawson & Witkop (1958) as described by Spande & Witkop (I967) .
Hepatitis B antigen of subtype ad was purified from the plasma of a healthy carrier by a combination of isopycnic banding and differential sedimentation on caesium chloride gradients . The purified antigen was devoid of detectable human plasma proteins as determined by gel-diffusion analysis with antiserum to normal human serum. The antigen thus prepared was extensively dialysed against saline.
A known amount of the purified protein in saline with E280 = I.I was frozen and lyophilized. The sample was then dissolved in o'5 ml of 8.o M-urea at pH 4"o (adjusted with acetic acid) and scanned from 25o to 4oo nm on a Zeiss Spectrophotometer. To the constantly stirred o'5 ml HB,Ag solution, lO#1 samples of lO mM-NBS solution were added at intervals of 15 min. The/?28o was recorded each time until there was no further change. The sample was scanned once again from 25o to 4oo nm (Fig. I) . A decrease in E280 was also observed in 8.o M-urea with oq5 M-NaC1 at pH 4"o in comparison with the spectrum of an identical amount of HB~Ag in saline. Corrections for this effect and the dilution produced by addition of NBS were applied in calculating the tryptophan content. Tryptophan content revealed by this method was I3"9 ~ or 22. 4 residues/mol of protein based on a tool. wt. of 3oooo used in the calculation. The value of tryptophan derived * Conditions of NBS treatment are described in the test. Untreated sample was subjected to conditions identical with the treated sample except for NBS treatment. Amount of protein was the same in treated and untreated samples. Radioimmunoassay was carried out according to instructions supplied with the kits (Abbott Laboratories, AUSTRIA TM n~l).
from this investigation coupled with the previously determined tyrosine content accounted well for the molar extinction coefficient of the protein. Reduction of the protein with fl-mercaptoethanol followed by alkylation according to the method previously described (Vyas, Rao & Ibrahim, I972) did not yield increased tryptophan content on titration with NBS, indicating that most of the tryptophan residues are available for titration with NBS at pH 4"o in 8.o M-urea. No decrease in E280 was observed after dialysis of the NBS treated HB~Ag, indicating no detectable cleavage of protein by NBS into dialysable peptides. When twofold dilutions of HB~Ag, with and without NBS treatment, were tested by radioimmunoassay (Abbott Laboratories, AUSTRIA TM II25), no significant loss of serologic activity was observed as a result of the NBS treatment (Table Q. From the 
